Peer-reviewedLicence not statedJournal of Diabetes and Metabolic Disorders4 Nov 2026

Ursolic acid as a multi-target therapeutic candidate in type 2 diabetes mellitus: a mechanistic and translational review

Farheen Sami¹
Lakhvir Kaur¹
Vir Vikram¹
Vinod Kumar^2,3
Mohammed Tahir Ansari⁴

4 affiliations

¹Department of Pharmaceutical Sciences, CT University, Ferozepur Road, Sidhwan Khurd, Ludhiana, Punjab 142024 India
²Kingston Imperial Institute of Technology and Sciences, Kaanswali Kothri, Kaanswali Kothri, Dunga, Dehradun Uttarakhand, 248007 India
³School of Pharmacy, GRD Uttarakhand University, Dehradun, Uttarakhand 248009 India
⁴Leicester School of Pharmacy, Faculty of Health and Sciences, De Montfort University, Gateway House, Leicester, LE1 9BH United Kingdom

Read full text DOI Cite

Natural Products in Diabetes Mellitus: A Narrative Review of Mechanistic Insights into Metabolic Regulation and Therapeutic Potential
Hemalata Deshmukh, Ganesh J. Kshirsagar, Lauren Gollahon
Nutrients10 Oct 2026Peer-reviewedCC BY 4.0Endocrinology & metabolismCrossref
Formononetin as a Natural Product-Derived Candidate for Diabetic Microvascular Complications: Mechanistic Evidence, Pharmacokinetics, Formulation Strategies, and Translational Barriers
Xiaotian Gao, Yingtao Zhang, Yan Zheng +11
Drug Design, Development and Therapy28 Oct 2026Peer-reviewedCC BY-NC 4.0Full textPharmacology & toxicologyPMCEurope PMC
Circadian Misalignment and Chrononutrition in Type 2 Diabetes: Mechanistic Insights and Translational Gaps.
İsmail Celil Haskoloğlu, Zeynep Güneş Özünal
International journal of molecular sciences23 Sep 2026Peer-reviewedCC BYFull textPhysiologyEurope PMC
Targeting Gut Microbiota, Inflammation, and Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: Therapeutic Strategies and the Emerging Role of Time-Restricted Feeding
Sthembiso Msane, Andile Khathi
Cells8 Oct 2026Peer-reviewedCC BY 4.0PhysiologyCrossref
The SLC7A11–ferroptosis axis in BRCA1-mutant breast cancer: current mechanistic evidence, potential therapeutic vulnerabilities, and translational perspectives
Yuying Yang, Yu Li, Xiaoyu Hao +2
Frontiers in Oncology30 Oct 2026Peer-reviewedCC BY 4.0OncologyFrontiersCrossref

Cite

BibTeX RIS

BibTeX

@article{sami2026ursolic,
  title = {{Ursolic acid as a multi-target therapeutic candidate in type 2 diabetes mellitus: a mechanistic and translational review}},
  author = {Farheen Sami and Lakhvir Kaur and Vir Vikram and Vinod Kumar and Mohammed Tahir Ansari},
  journal = {Journal of Diabetes and Metabolic Disorders},
  year = {2026},
  month = nov,
  doi = {10.1007/s40200-026-02086-0},
  url = {https://doi.org/10.1007/s40200-026-02086-0},
}

RIS

TY  - JOUR
TI  - Ursolic acid as a multi-target therapeutic candidate in type 2 diabetes mellitus: a mechanistic and translational review
AU  - Farheen Sami
AU  - Lakhvir Kaur
AU  - Vir Vikram
AU  - Vinod Kumar
AU  - Mohammed Tahir Ansari
PY  - 2026
DA  - 2026/11/04
JO  - Journal of Diabetes and Metabolic Disorders
DO  - 10.1007/s40200-026-02086-0
UR  - https://doi.org/10.1007/s40200-026-02086-0
SN  - 2251-6581
ER  -

Related

Cite